pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,763 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 252 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings252
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT04398082: TRANslating Sleep Health Into QUaLity of Recovery (TRANQUiL) Study

Sponsor: Women's College Hospital. Phase: . Conditions: Sleep Disorder, Sleep Disturbance

full page →ctgov ↗
›RECRUITINGphase readoutNCT06941324: Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

Sponsor: University of Michigan Rogel Cancer Center. Phase: NA. Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT07368959: AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction

Sponsor: Aurion Biotech. Phase: PHASE3. Conditions: Corneal Edema, Corneal Endothelial Dysfunction, Fuchs Endothelial Corneal Dysfunction, Pseudophakic Bullous Keratopathy (PBK)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07511959: Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry

Sponsor: Wroclaw Medical University. Phase: . Conditions: Temporomandibular Disorders (TMD), Muscle Pain, TMJ Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT04739059: Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

Sponsor: CSL Behring. Phase: PHASE3. Conditions: Hereditary Angioedema

full page →ctgov ↗
›RECRUITINGphase readoutNCT07012759: Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

Sponsor: Fu Jen Catholic University. Phase: . Conditions: Biomarkers, Lung Adenocarcinoma, Pleural Effusion

full page →ctgov ↗
›COMPLETEDphase readoutNCT02705859: Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study)

Sponsor: Cancer Trials Ireland. Phase: PHASE1. Conditions: HER2 Positive Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05407480: Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma

Sponsor: French Africa Pediatric Oncology Group. Phase: . Conditions: Staging, Therapeutic Recommendations

full page →ctgov ↗
›COMPLETEDphase readoutNCT05502796: Natural History and Pathogenesis of Alopecia in Children and Adults

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Phase: . Conditions: Hair Loss

full page →ctgov ↗
›RECRUITINGphase readoutNCT07361003: A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Refractory Metastatic Colorectal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03998527: Non-Invasive Spinal Cord Stimulation After Injury

Sponsor: University of Louisville. Phase: NA. Conditions: Spinal Cord Injuries

full page →ctgov ↗
›TERMINATEDphase readoutNCT05286827: Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Pancreatic Acinar Cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07030127: A Study of LY3985863 in Healthy Participants

Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07318727: Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment

Sponsor: Peking University People's Hospital. Phase: NA. Conditions: Endometrium Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07285473: Low-Dose Naltrexone For ME/CFS: Dose-Finding

Sponsor: University of Alabama at Birmingham. Phase: PHASE2. Conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07329569: Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: PHASE2. Conditions: Chemical Burns, Ocular Burns

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04973683: AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06643741: Non-Invasive Preeclampsia Screening and Biobank

Sponsor: Sequenom, Inc.. Phase: . Conditions: Preeclampsia (PE)

full page →ctgov ↗
›COMPLETEDphase readoutNCT00001254: Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Zollinger Ellison Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07383441: Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Sponsor: SWOG Cancer Research Network. Phase: PHASE3. Conditions: Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT06760754: Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Program Among Cancer Survivors Treated in a Safety Net Hospital

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07399405: Comparison of Nutrient Content Between Preterm and Term Human Milk: a Systematic Review and Meta-analysis

Sponsor: Sun Yat-sen University. Phase: . Conditions: Comparative Nutrient Composition of Preterm and Term Human Milk

full page →ctgov ↗
›RECRUITINGphase readoutNCT03680794: Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies

Sponsor: CHU de Reims. Phase: NA. Conditions: Diabetic Retinopathy, Retinal Vein Occlusion

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05006794: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Sponsor: Gilead Sciences. Phase: PHASE1. Conditions: Solid Malignancies

full page →ctgov ↗
›RECRUITINGphase readoutNCT07451340: Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women

Sponsor: Ankara University. Phase: . Conditions: Healthy, Cervical Cancer Screening

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07143968: A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

Sponsor: Naga P. Chalasani. Phase: PHASE2. Conditions: MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, HIV (Human Immunodeficiency Virus)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07411391: Supervised Endoscopic Tele-controlled Intelligent Lithotripsy

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Renal Stone

full page →ctgov ↗
›RECRUITINGphase readoutNCT07383974: The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status

Sponsor: ChinaNorm. Phase: NA. Conditions: Healthy Volunteers, Dietary Supplementation, Skin Health, Health Status, Antioxidants

full page →ctgov ↗
›COMPLETEDphase readoutNCT06713174: Interleukin 8 and10 Levels Changes in Teeth With Necrotic Pulp and Apical Periodontitis

Sponsor: Faculty of Dental Medicine for Girls. Phase: NA. Conditions: Pulp and Periapical Tissue Disease, Patients With Pulp Necrosis and Apical Periodontitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06244290: Dentinal Hypersensitivity Reduction

Sponsor: Colgate Palmolive. Phase: PHASE3. Conditions: Dentinal Hypersensitivity

full page →ctgov ↗
›RECRUITINGphase readoutNCT05128890: Evaluation of Resection Techniques for Pancreatic Tumors

Sponsor: Methodist Health System. Phase: . Conditions: Surgery, Liver Tumor, Pancreas Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT06406790: CraniSeal Post Approval Study

Sponsor: Pramand LLC. Phase: PHASE4. Conditions: Leak, Cerebrospinal Fluid

full page →ctgov ↗
›RECRUITINGphase readoutNCT02596490: Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT01520597: National Study on Listeriosis and Listeria

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Listeriosis, Pregnancy Complications, Infectious, Central Nervous System Infections, Septicemia, Sepsis; Listeria Monocytogenes

full page →ctgov ↗
›COMPLETEDphase readoutNCT05408013: The Prevalence of Insomnia in Patients With Psychiatric Disorders

Sponsor: University of Bern. Phase: . Conditions: Insomnia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06138613: Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Motion Sickness

full page →ctgov ↗
›RECRUITINGphase readoutNCT07018713: A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

Sponsor: Merz Therapeutics GmbH. Phase: PHASE3. Conditions: Chronic Migraine

full page →ctgov ↗
›COMPLETEDphase readoutNCT05599620: Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma

Sponsor: Lifespan. Phase: NA. Conditions: Alcohol Use, Unspecified, Sexual Dysfunction, Sexual Assault

full page →ctgov ↗
›RECRUITINGphase readoutNCT05746182: Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

Sponsor: University of California, San Francisco. Phase: . Conditions: Pancreatic Neuroendocrine Neoplasm

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01599559: Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

Sponsor: International Extranodal Lymphoma Study Group (IELSG). Phase: NA. Conditions: Primary Mediastinal B-cell Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06768359: The Effect of Manual Acupuncture and Standard Therapy on Anxiety and Quality of Life Scores in Cancer Patients

Sponsor: Indonesia University. Phase: NA. Conditions: Anxiety, Quality of Life, Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT04340180: Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction

Sponsor: University of Alabama at Birmingham. Phase: PHASE1. Conditions: Breast Benign Tumor, Breast Malignant Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07220096: Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05928403: Rate of Return to Sport After Total Knee Prosthesis: Comparison of Three Types of Prostheses

Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche. Phase: . Conditions: Knee Arthropathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06245603: A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

Sponsor: Istituto Oncologico Veneto IRCCS. Phase: NA. Conditions: Non-muscle Invasive Bladder Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07136103: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants

Sponsor: AbbVie. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›AVAILABLEphase readoutNCT05795361: Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

Sponsor: Takeda. Phase: . Conditions: Hunter Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07538661: Metabolic Regeneration Registry for Periodontal Health (20-Patient Cohort).

Sponsor: Amar h Zireg. Phase: . Conditions: Chronic Periodontitis, Chronic Periodontitis Wth Diabetes Mellitus, Non-surgical Periodontal Treatment, Gingival Regeneration, Metabolic Repair

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07386561: Virtual Reality Therapy and Non-Sleep Deep Rest Relaxation After Joint Arthroplasty

Sponsor: Wroclaw University of Health and Sport Sciences. Phase: NA. Conditions: Arthropathy, Osteoarthritis, Hip, Osteoarthritis, Knee

full page →ctgov ↗
›RECRUITINGphase readoutNCT07032662: IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Sponsor: Immunovant Sciences GmbH. Phase: PHASE2. Conditions: Chronic Inflammatory Demyelinating Polyneuropathy

full page →ctgov ↗
← prev
page 64 of 156
next →